SCHEMBL10332129

SCHEMBL10332129

Bc1cccc(-c2cc3ccccc3c3ccccc23)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.51
ALDH1A1 P00352 6/20 0.46
HSD17B10 Q99714 5/20 0.46
HPGD P15428 4/20 0.46
HIF1A Q16665 2/20 0.46
TSHR P16473 2/20 0.46
MAPK1 P28482 1/20 0.46
CASP1 P29466 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
MPI P34949 1/20 0.43
TRPM4 Q8TD43 1/20 0.41
CYP1B1 Q16678 1/20 0.40
HPRT1 P00492 1/20 0.38
NISCH Q9Y2I1 1/20 0.38
CYP1A2 P05177 3/20 0.37
ERBB2 P04626 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12520786 0.84 CYP11B1 (0.58) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL10332085 0.82 MCL1 (0.46) ALDH1A1HSD17B10HPGDHIF1ATSHR
SCHEMBL17899358 0.81 CYP11B1 (0.45) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL12655579 0.81 ALDH1A1 (0.42) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL29006475 0.80 CYP11B1 (0.55) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL30340805 0.80 CYP11B1 (0.55) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL10124865 0.80 CYP11B1 (0.50) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL17541721 0.79 CA12 (0.46) ALDH1A1HSD17B10HPGDTSHRMAPK1
SCHEMBL10285373 0.79 ALDH1A1 (0.48) ALDH1A1HSD17B10HPGDHIF1ATSHR
SCHEMBL5851578 0.79 ALDH1A1 (0.63) CYP11B1ALDH1A1HSD17B10HPGDHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108352456-B Organic electroluminescent device 诺瓦尔德股份有限公司 2020-03-20 CN disclosed
US-8221907-B2 Chrysene derivative and organic electroluminescent device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-07-17 US disclosed
US-20100194270-A1 CHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100194270-A1 CHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME RPS10, OR10J3, RPS25 CYP11B1 1411/4885ALDH1A1 2760/4885HSD17B10 1104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.